<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">67555</article-id><article-id pub-id-type="doi">10.7554/eLife.67555</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Two <italic>de novo</italic> GluN2B mutations affect multiple NMDAR-functions and instigate severe pediatric encephalopathy</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-232003"><name><surname>Kellner</surname><given-names>Shai</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-232013"><name><surname>Abbasi</surname><given-names>Abeer</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-241866"><name><surname>Carmi</surname><given-names>Ido</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-232005"><name><surname>Heinrich</surname><given-names>Ronit</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-232006"><name><surname>Garin-Shkolnik</surname><given-names>Tali</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-232007"><name><surname>Hershkovitz</surname><given-names>Tova</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-241863"><name><surname>Giladi</surname><given-names>Moshe</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-241864"><name><surname>Haitin</surname><given-names>Yoni</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-232008"><name><surname>Johannesen</surname><given-names>Katrine M</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-136282"><name><surname>Steensbjerre Møller</surname><given-names>Rikke</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-226656"><name><surname>Berlin</surname><given-names>Shai</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5153-4876</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Neuroscience</institution>, <institution>Technion- Israel Institute of Technology</institution>, <addr-line><named-content content-type="city">Haifa</named-content></addr-line>, <country>Israel</country></aff><aff id="aff2"><institution content-type="dept">Dermatology</institution>, <institution>Clalit health services</institution>, <addr-line><named-content content-type="city">Yoqneam</named-content></addr-line>, <country>Israel</country></aff><aff id="aff3"><institution content-type="dept">Genetics Institute</institution>, <institution>Rambam medical center</institution>, <addr-line><named-content content-type="city">Haifa</named-content></addr-line>, <country>Israel</country></aff><aff id="aff4"><institution>Tel Aviv University</institution>, <addr-line><named-content content-type="city">Tel Aviv</named-content></addr-line>, <country>Israel</country></aff><aff id="aff5"><institution content-type="dept">Department of Epilepsy Genetics and Personalized Medicine Danish Epilepsy Centre</institution>, <institution>University of Southern Denmark</institution>, <addr-line><named-content content-type="city">Dianalund</named-content></addr-line>, <country>Denmark</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-13593"><name><surname>Chao</surname><given-names>Moses V</given-names></name><role>Reviewing editor</role><aff><institution>New York University Langone Medical Center</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>shai.berlin@technion.ac.il</email> (SB);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>02</day><month>07</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e67555</elocation-id><history><date date-type="received"><day>15</day><month>02</month><year>2021</year></date><date date-type="accepted"><day>27</day><month>06</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Kellner et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Kellner et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-67555-v1.pdf"/><abstract><p>The N-methyl-D-aspartate receptors (NMDARs; GluNRS) are glutamate receptors, commonly located at excitatory synapses. Mutations affecting receptor function often lead to devastating neurodevelopmental disorders. We have identified two toddlers with different heterozygous missense mutations of the same, and highly conserved, glycine residue located in the ligand-binding-domain of <italic>GRIN2B</italic>: G689C and G689S. Structure simulations suggest severely impaired glutamate binding which we confirm by functional analysis. Both variants show three-orders of magnitude reductions in glutamate EC<sub>50</sub>, with G689S exhibiting the largest reductions observed in <italic>GRIN2B</italic> (~2000-fold). Moreover, variants multimerize with, and upregulate, GluN2B<italic>wt</italic>-subunits, thus engendering a strong dominant-negative effect on mixed channels. In neurons, overexpression of the variants instigates suppression of synaptic GluNRs. Lastly, while exploring spermine potentiation as a potential treatment, we discovered that the variants fail to respond due to G689's novel role in proton-sensing. Together, we describe two unique variants with extreme effects on channel function. We employ protein-stability measures to explain why current (and future) LBD mutations in GluN2B primarily instigate Loss-of-Function.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Xenopus</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003977</institution-id><institution>Israel Science Foundation</institution></institution-wrap></funding-source><award-id>1096/17</award-id><principal-award-recipient><name><surname>Berlin</surname><given-names>Shai</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100006259</institution-id><institution>Teva Pharmaceutical Industries</institution></institution-wrap></funding-source><award-id>PR783187</award-id><principal-award-recipient><name><surname>Kellner</surname><given-names>Shai</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All Experiments were approved by the Technion Institutional Animal Care and Use Committee (permit SB, no. IL-129-09-17).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files. Raw data is deposited at Dryad (doi:10.5061/dryad.1jwstqjv3)</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Kellner S</collab><collab>Abbasi A</collab><collab>Heinrich R</collab><collab>Garin-Shkolnik T</collab><collab>Hershkovitz T </collab><collab>Johannesen KM</collab><collab>Møller RS</collab><collab>Berlin S</collab></person-group><year iso-8601-date="2021">2021</year><source>Two de novo GluN2B mutations affect multiple NMDAR-functions and instigate severe pediatric encephalopathy</source><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.5061/dryad.1jwstqjv3">http://dx.doi.org/10.5061/dryad.1jwstqjv3</ext-link><comment>Dryad Digital Repository, doi:10.5061/dryad.1jwstqjv3</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-67555-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>